Prognostic value of circulating endothelial cells in glioblastoma patients: a pilot study.

Future Sci OA · 2022 · PMC9136629 · PMID 35662744

Europe PMC DOI

hedged sentence

0.0970

closest p · 1.9× alpha

0.0970

boldest claim

The sentences

did not reach statistical significancep = 0.097so close (0.05 < p ≤ 0.1)

Furthermore, the median progression free survival was higher in group 1, 8.94 months (IC 95%: 5.1–12.69) versus 3.95 months (IC 95%: 2.91–4.98) for group 2, but did not reach statistical significance (p = 0.097, Figure 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.